Skip to main content
Clinical Trials/NCT05524350
NCT05524350
Active, not recruiting
Not Applicable

Study of the Total Hip Prosthesis With a HYPE Stem in Hip Arthroplasty

Societe dEtude, de Recherche et de Fabrication2 sites in 1 country180 target enrollmentDecember 5, 2017
ConditionsHip Arthropathy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hip Arthropathy
Sponsor
Societe dEtude, de Recherche et de Fabrication
Enrollment
180
Locations
2
Primary Endpoint
Survival rate
Status
Active, not recruiting
Last Updated
8 days ago

Overview

Brief Summary

The use of cementless femoral stems is known to provide satisfactory long-term clinical results. Extensive and durable osseointegration of these implants has been reported in numerous series, despite the use of stems with different geometry and coating distribution.

This study will validate the performance and safety of the HYPE (SERF) stems in the context of the 93/42/EEC directive and in relation to the recommendations of the MEDDEV 2.7.1 (Guideline for post-marketing follow-up), which provides for a systematic procedure for monitoring clinical data in order to verify the performance claimed for medical devices.

Registry
clinicaltrials.gov
Start Date
December 5, 2017
End Date
January 20, 2031
Last Updated
8 days ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Societe dEtude, de Recherche et de Fabrication
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female
  • Degenerative or inflammatory hip disease requiring total hip replacement
  • Primary or secondary osteoarthritis,
  • Advanced joint destruction resulting from rheumatoid arthritis or traumatic origin,
  • Avascular fracture or necrosis,
  • Displaced subcapital and transcervical fracture as well as PAPROSKY stages I to IIB bone defects.
  • Joint destruction of traumatic origin
  • Following a previous operation, provided that the new device does not interfere with the material in place (osteosynthesis, joint reconstruction, arthrodesis, hemiarthroplasty, total arthroplasty).

Exclusion Criteria

  • Patient with a psychological, family, sociological or geographical situation likely to hinder compliance with the study protocol and follow-up
  • Known pregnancy in progress
  • Breastfeeding
  • Patient requiring a bone graft
  • Neurological disorders or other pathology that may influence locomotion
  • History of sepsis in the hip to be operated on
  • Short-term vital prognosis

Outcomes

Primary Outcomes

Survival rate

Time Frame: Per operative period to 10 years

Survival rate for failure at 10 years by studying in particular the intraosseous behaviour of the stem (femoral implant) and of the acetabulum (acetabular or acetabular implant) with the help of radiological examinations: appearance or not of lines, osseointegration, migration, possible loosening, realignment.

Secondary Outcomes

  • Patient satisfaction(Per operative period to 10 years)
  • Pain release(Per operative period to 10 years)
  • Functional improvement(Per operative period to 10 years)
  • Adverse event(Per operative period to 10 years)

Study Sites (2)

Loading locations...

Similar Trials